Canadian Price Controls May Become Higher Priority For PhRMA
Executive Summary
The impact of international pharmaceutical price controls on the U.S. Medicare debate may be leading PhRMA to step up its international lobbying efforts, particularly in Canada.
You may also be interested in...
Pequot Indians Directed To Stop Supplying FSS Priced Drugs To Employees
The Mashantucket Pequot Tribal Nation should stop providing pharmaceuticals to non-Indian employees of the Foxwoods casino at federal discounted prices, the Indian Health Service told the tribe.
Pequot Indians Directed To Stop Supplying FSS Priced Drugs To Employees
The Mashantucket Pequot Tribal Nation should stop providing pharmaceuticals to non-Indian employees of the Foxwoods casino at federal discounted prices, the Indian Health Service told the tribe.
HHS Will Consult With USTR On Patent Relief Claims From Foreign Countries
HHS will have a formal consulting role in future decisions by the U.S. Trade Representative about claims from foreign governments that patent laws hinder their ability to address a public health emergency.